Nasal Drug Delivery CDMO Market
完整報告名稱與涵蓋範圍
Nasal Drug Delivery CDMO Market Size, Share & Trends Analysis Report, By Service Type (Nasal Formulation Development, Device Selection and Combination Product Development, Clinical and Commercial Filling and Assembly, Analytical, Regulatory and Bioequivalence Support), By Dosage Form (Aqueous Sprays, Nasal Powders, Suspensions, Gels and Novel Formulations), By Molecule Type (Small Molecules, Peptides and Biologics, Vaccines and Nucleic Acids), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The nasal drug delivery CDMO market covers outsourced development and manufacturing services for intranasal products, including formulation development, device selection and combination product engineering, spray characterisation and analytical testing, regulatory and bioequivalence support and clinical and commercial filling and assembly of sprays, powders and novel formulations. Captive manufacturing by pharmaceutical companies and the sale of finished nasal products are excluded.
Outsourcing demand has risen with the diversification of nasal therapies into rescue medicines, migraine treatment, peptides and vaccines, each requiring expertise in spray pattern, droplet size and nasal deposition that most sponsors lack in house. Nasal generics have become a distinct growth area as branded steroid, triptan and naloxone products lose exclusivity and regulators apply detailed in-vitro and clinical bioequivalence frameworks that reward specialised analytical capability. Providers are adding aseptic and preservative-free filling lines, unit-dose and powder capabilities, device-agnostic development platforms and integrated regulatory support, while consolidation among pump suppliers and CDMOs is reshaping the supply base.
North America and Europe host most capacity and demand, with India and China expanding low-cost nasal generic manufacturing. Competition involves dedicated nasal specialists, diversified CDMOs with inhalation and nasal franchises and device companies offering development services.
The InsightAce study includes revenue forecasts in US$ for all service type, dosage form, molecule type and end user and regional segments across 2026-2035, segment-level trend analysis, competitive positioning assessment and company profiles.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Nasal Drug Delivery CDMO Market Snapshot
Chapter 4. Global Nasal Drug Delivery CDMO Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Service Type Estimates & Trend Analysis
5.1. Service Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Service Type:
5.2.1. Nasal Formulation Development
5.2.2. Device Selection and Combination Product Development
5.2.3. Clinical and Commercial Filling and Assembly
5.2.4. Analytical, Regulatory and Bioequivalence Support
Chapter 6. Market Segmentation 2: By Dosage Form Estimates & Trend Analysis
6.1. Dosage Form & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Dosage Form:
6.2.1. Aqueous Sprays
6.2.2. Nasal Powders
6.2.3. Suspensions, Gels and Novel Formulations
Chapter 7. Market Segmentation 3: By Molecule Type Estimates & Trend Analysis
7.1. Molecule Type & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Molecule Type:
7.2.1. Small Molecules
7.2.2. Peptides and Biologics
7.2.3. Vaccines and Nucleic Acids
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Pharmaceutical Companies
8.2.2. Biotechnology Companies
8.2.3. Generic and OTC Manufacturers
Chapter 9. Nasal Drug Delivery CDMO Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Recipharm AB
11.2. Catalent (Novo Nordisk A/S)
11.3. Aptar Pharma (Nanopharm and Gateway Analytical)
11.4. Renaissance Lakewood, LLC
11.5. Hikma Pharmaceuticals PLC
11.6. Aurena Laboratories AB
11.7. Curida AS
11.8. Nephron Pharmaceuticals Corporation
11.9. Pharmaceutical Associates, Inc.
11.10. Cambrex Corporation
11.11. Vectura Fertin Pharma
11.12. Bespak (Recipharm)
11.13. Padagis LLC
11.14. Zhejiang Xianju Pharmaceutical Co., Ltd.
11.15. Lupin Ltd.
圖表清單 List of Tables & Figures
Table 1. Global Nasal Drug Delivery CDMO Market Revenue Forecast by Service Type, 2026-2035 (US$ Mn)
Figure 1. Global Nasal Drug Delivery CDMO Market Segmentation and Scope Overview
Table 2. Global Nasal Drug Delivery CDMO Market Revenue Forecast by Dosage Form, 2026-2035 (US$ Mn)
Figure 2. Global Nasal Drug Delivery CDMO Market Share by Service Type, 2026 & 2035
Table 3. Global Nasal Drug Delivery CDMO Market Revenue Forecast by Molecule Type, 2026-2035 (US$ Mn)
Figure 3. Nasal CDMO Service Stack from Formulation to Combination Product Registration
Table 4. Global Nasal Drug Delivery CDMO Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Nasal Generic Pipeline and Bioequivalence Requirements by Reference Product
Table 5. Global Nasal Drug Delivery CDMO Market Revenue Forecast by Region, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Nasal Drug Delivery CDMO Growth Opportunity Analysis
Table 6. North America Nasal Drug Delivery CDMO Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Competitive Positioning of Key Nasal Drug Delivery CDMO Market Participants
Table 7. Europe Nasal Drug Delivery CDMO Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Porter's Five Forces Analysis of the Global Nasal Drug Delivery CDMO Market
Table 8. Asia Pacific Nasal Drug Delivery CDMO Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Preservative-Free and Unit-Dose Filling Capacity Expansion Among Providers
Table 9. Strategic Developments of Leading Nasal Drug Delivery CDMO Market Participants, 2023-2026
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們